For instance, high titers of anti-CA I autoantibodies were observed in sera of patients with Hodgkin's disease, multiple myeloma, and some other hemato-oncological malignancies after high-dose therapy (HDT) combined with autologous stem cell transplantation (ASCT) [29]. Here, CA1 is linked to plasma cell myeloma.